Accuray (ARAY) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,005.00 |
| Dec 31, 2025 | -1,964.00 |
| Sep 30, 2025 | -2,544.00 |
| Jun 30, 2025 | 2,455.00 |
| Mar 31, 2025 | -294.00 |
| Dec 31, 2024 | -1,205.00 |
| Sep 30, 2024 | 940.00 |
| Jun 30, 2024 | 2,383.00 |
| Mar 31, 2024 | -779.00 |
| Dec 31, 2023 | -1,068.00 |
| Sep 30, 2023 | -1,272.00 |
| Jun 30, 2023 | 1,975.00 |
| Mar 31, 2023 | 882.00 |
| Dec 31, 2022 | 519.00 |
| Sep 30, 2022 | -2,805.00 |
| Jun 30, 2022 | 2,031.00 |
| Mar 31, 2022 | 259.00 |
| Dec 31, 2021 | 1,236.00 |
| Sep 30, 2021 | 153.00 |
| Jun 30, 2021 | 3,880.00 |
| Mar 31, 2021 | -405.00 |
| Dec 31, 2020 | 1,283.00 |
| Sep 30, 2020 | 1,700.00 |
| Jun 30, 2020 | 972.00 |
| Mar 31, 2020 | 552.00 |
| Dec 31, 2019 | 2,254.00 |
| Sep 30, 2019 | 1,541.00 |
| Jun 30, 2019 | 855.00 |
| Mar 31, 2019 | 349.00 |
| Dec 31, 2018 | 120.00 |
| Sep 30, 2018 | 601.00 |
| Jun 30, 2018 | 2,114.00 |
| Mar 31, 2018 | 3,671.00 |
| Dec 31, 2017 | 3,289.00 |
| Sep 30, 2017 | 1,990.00 |
| Jun 30, 2017 | -2,008.00 |
| Mar 31, 2017 | 1,049.00 |
| Dec 31, 2016 | -398.00 |
| Sep 30, 2016 | 1,422.00 |
| Jun 30, 2016 | 21,567.00 |
| Mar 31, 2016 | 258.00 |
| Dec 31, 2015 | -1,288.00 |
| Sep 30, 2015 | 132.00 |